Massachusetts Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-95,547
| Closed | -$1.77M | – | 883 |
|
|
2023
Q3 | $1.77M | Buy |
95,547
+22,802
| +31% | +$423K | ﹤0.01% | 730 |
|
|
2023
Q2 | $805K | Sell |
72,745
-1,714
| -2% | -$19K | ﹤0.01% | 765 |
|
|
2023
Q1 | $1,000K | Sell |
74,459
-85,004
| -53% | -$1.14M | ﹤0.01% | 756 |
|
|
2022
Q4 | $1.97M | Buy |
159,463
+3,376
| +2% | +$41.8K | ﹤0.01% | 728 |
|
|
2022
Q3 | $2.18M | Sell |
156,087
-1,423
| -0.9% | -$19.8K | ﹤0.01% | 710 |
|
|
2022
Q2 | $2.18M | Buy |
157,510
+795
| +0.5% | +$11K | ﹤0.01% | 714 |
|
|
2022
Q1 | $2.55M | Buy |
156,715
+1,607
| +1% | +$26.1K | ﹤0.01% | 731 |
|
|
2021
Q4 | $2.53M | Buy |
155,108
+102,965
| +197% | +$1.68M | ﹤0.01% | 753 |
|
|
2021
Q3 | $774K | Buy |
+52,143
| New | +$774K | ﹤0.01% | 852 |
|
|
2016
Q2 | – | Sell |
-51,588
| Closed | -$6.63M | – | 877 |
|
|
2016
Q1 | $6.63M | Sell |
51,588
-13,056
| -20% | -$1.68M | ﹤0.01% | 612 |
|
|
2015
Q4 | $9.65M | Sell |
64,644
-449
| -0.7% | -$67.1K | 0.01% | 592 |
|
|
2015
Q3 | $10.8M | Sell |
65,093
-14,489
| -18% | -$2.4M | 0.01% | 584 |
|
|
2015
Q2 | $19.2M | Sell |
79,582
-8,616
| -10% | -$2.08M | 0.01% | 532 |
|
|
2015
Q1 | $24.9M | Buy |
88,198
+1,986
| +2% | +$560K | 0.01% | 477 |
|
|
2014
Q4 | $13.4M | Buy |
+86,212
| New | +$13.4M | 0.01% | 590 |
|
|
2014
Q2 | – | Sell |
-4,400
| Closed | -$1.45M | – | 922 |
|
|
2014
Q1 | $1.45M | Buy |
+4,400
| New | +$1.45M | ﹤0.01% | 724 |
|